In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

The stock's fall snapped a two-day winning streak.

The Food and Drug Administration issued a notice on Friday classifying its recall of the Boston Scientific Accolade pacemaker devices as the most serious type of recall. To date, 832 injuries and ...